Trademark: BINA 1910477
Word
BINA
ID
1910477
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
09 February 2018
Registration Date
09 February 2018
Renewal Date
10 December 2025
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 9:
Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
Downloadable computer databases containing information in the field of genomics, cancer research and cancer treatments; downloadable software for accessing, organizing, interpreting and analyzing information from databases in the fields of genomics, cancer research and cancer treatments; laboratory apparatus for sequencing of genomic DNA; computer databases, in particular biomedical computer databases containing information about clinical, molecular, scientific and patient specific data, in particular for the integration, interpretation and analysis of cancer genomic information, biomarker information; computer software for authorizing access to these biomedical databases, in particular application software, interface software, software drives, data communication software and interactive computer software
Class 42:
Electronic data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; electronic data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to the patients clinical responses to drug treatments and treatment regimes; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing scientific information on patients' genomic changes that contribute to an unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of patients; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an on-line, non-downloadable computer platform for purposes of storing and providing information about an individual's cancer profile and genomic changes of individuals to enable physicians and healthcare professionals to optimize treatment in clinical practice
Electronic data collection for analytical and clinical purposes, in particular the collection and systematic sorting of specific molecular, genomic and/or clinical data relating to genomic changes, namely, cancer genomic changes, of an individual, namely of a cancer patient; providing scientific information through the collection and analysis of genetic information and information regarding the treatment of cancer and other diseases and disorders; electronic data collection for analytical purposes, in particular the collection of mathematical and statistical data, clinical data, genomic data and data of clinical studies relating to the patients clinical responses to drug treatments and treatment regimes; providing scientific advice in the fields of cancer biology, cancer treatment, pharmaceutical side effects, genomics, cancer medicine and translational medicine; providing scientific analysis and analysis services in the field of next generation sequencing (NGS), namely, the analysis and interpretation of genomic data obtained from cancer patients; providing scientific information on patients' genomic changes that contribute to an unique cancer disease; providing research information about drug safety and drug compatibility in relation to cancer therapy and the treatment of patients; scientific consulting services in the fields of pharmaceuticals and genetics, in particular conducting scientific research in drug safety and dosage assessment and drug compatibility studies in the field of cancer treatment therapy for others; electronic storage of medical data and information for physicians and healthcare professionals; providing an on-line, non-downloadable computer platform for purposes of storing and providing information about an individual's cancer profile and genomic changes of individuals to enable physicians and healthcare professionals to optimize treatment in clinical practice